These studies thus serve to help validate our burden test methodology, and provide important independent replication, further cementing these genetic findings for TOF, replicating NOTCH1 for the first time, and collectively supporting study designs that focus on TOF within the heterogeneous umbrella of CHD. The gene discussed is NOTCH1; the disease is coronary artery disorder.